TAMpering with Toll-like Receptor Signaling

Slides:



Advertisements
Similar presentations
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Advertisements

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Alexander Loewer, Galit Lahav  Cell 
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
A Nurr1 Pathway for Neuroprotection
Cytokines, Skin, and Smallpox–A New Link to an Antimicrobial Peptide
Amit Awasthi, Vijay K. Kuchroo  Immunity 
NF-κB: A Coordinator for Epigenetic Regulation by MLL
CD5: A New Partner for IL-6
Innate DNA Sensing Moves to the Nucleus
Toll-like Receptors Keep Antigen Sorting on the Right Track
The Birds, the Bees, and Innate Immunity
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Toll-like receptor activation: from renal inflammation to fibrosis
Immunomodulation in the critically ill
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Boosting the Brain's Ability to Block Inflammation via MicroRNA-132
Fishing Out a Sensor for Anti-inflammatory Oils
Sweet! Helicobacter Sugar Calms Intestinal Macrophages
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
Cyclic Dinucleotides and the Innate Immune Response
Dissecting a Hub for Immune Response: Modeling the Structure of MyD88
Pathogen Recognition and Innate Immunity
Volume 49, Issue 1, Pages 4-8 (January 2006)
Ning Li, Sergei I. Grivennikov, Michael Karin  Cancer Cell 
Shannon M. Kahan, Allan J. Zajac  Immunity 
Maintaining Poise: Commensal Microbiota Calibrate Interferon Responses
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Eukaryotic Transcription Activation: Right on Target
Stuart M. Levitz, Douglas T. Golenbock  Cell 
Inflammation Joins the “Niche”
Connecting Mitochondria and Innate Immunity
Dampening NF-κB Signaling by “Self-Eating”
In Vivo Role of pDCs in Regulating Adaptive Immunity
Stuart M. Levitz, Douglas T. Golenbock  Cell 
Why Worms Watch Their Hemidesmosomes and Why You Should, Too
The RAS/MAPK Axis Gets Stressed Out
Inflammasome Activation: How Macrophages Watch What They Eat
The cGAS-STING Defense Pathway and Its Counteraction by Viruses
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Nanna Fyhrquist, Sampsa Matikainen, Antti Lauerma 
Superficial Immunity: Antimicrobial Responses Are More Than Skin Deep
How Low Cholesterol Is Good for Anti-viral Immunity
Roles of Caspases in Necrotic Cell Death
Taro Kawai, Shizuo Akira  Immunity  Volume 34, Issue 5, Pages (May 2011)
p38δ and PKD1: Kinase Switches for Insulin Secretion
Fishing Out a Sensor for Anti-inflammatory Oils
Volume 143, Issue 6, (December 2010)
TLR2 Looks at Lipoproteins
Interleukin signaling
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
“Transflammation”: When Innate Immunity Meets Induced Pluripotency
IL-7 Knocks the Socs Off Chronic Viral Infection
Innate Recognition of Viruses
DNA Makes RNA Makes Innate Immunity
Cytokine Signaling Modules in Inflammatory Responses
Sterile Inflammation Fuels Gastric Cancer
Teeing Up Transcription on CpG Islands
Intracellular NOD-like Receptors in Host Defense and Disease
Releasing the Brakes on Cancer Immunotherapy
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Mesenchymal Stromal Cells: New Directions
Figure 5 TLR-dependent signaling pathways inhibited by glatiramer acetate Myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1 receptor.
Conformational Ensembles in GPCR Activation
Volume 27, Issue 5, Pages (November 2007)
Why Worms Watch Their Hemidesmosomes and Why You Should, Too
NF-κB, Inflammation, and Metabolic Disease
Toll-like receptors, adapter proteins, and signaling molecules.
Presentation transcript:

TAMpering with Toll-like Receptor Signaling Luke A.J. O'Neill  Cell  Volume 131, Issue 6, Pages 1039-1041 (December 2007) DOI: 10.1016/j.cell.2007.11.032 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Inhibition of TLR Signaling by TAM Receptors Rothlin et al. (2007) propose a tripartite model for TLR action. In the first stage (1), an initial response is triggered by TLRs via adaptor proteins that lead to activation of TRAF3 and TRAF6. In turn, TRAF3 and TRAF6 activate the transcription factors IRF3 and NF-κB, respectively, leading to production of cytokines, notably type I interferons, which promote host defense and inflammation. In the second stage (2), interferon signaling has a positive feedforward effect, promoting further interferon production via STAT1, thereby amplifying the response. However, in the third stage (3), interferons also induce inhibitory TAM receptors via STAT1 in a negative feedback effect. The TAM receptor ligands Gas6 and ProS also activate STAT1, which selectively induces production of SOCS1 and SOCS3. These proteins mediate the inhibition of TLR signaling by targeting Mal in the case of SOCS1 and TRAF3 and TRAF6 in the case of SOCS3. Together, this process allows the innate immune response to be launched but ultimately ensures that it is self-limiting and therefore not detrimental to the host. Cell 2007 131, 1039-1041DOI: (10.1016/j.cell.2007.11.032) Copyright © 2007 Elsevier Inc. Terms and Conditions